Authors:
Waltregny, D
Leav, I
Signoretti, S
Soung, P
Lin, D
Merk, F
Adams, JY
Bhattacharya, N
Cirenei, N
Loda, M
Citation: D. Waltregny et al., Androgen-driven prostate epithelial cell proliferation and differentiationin vivo involve the regulation of p27, MOL ENDOCR, 15(5), 2001, pp. 765-782
Authors:
De Pinieux, G
Flam, T
Zerbib, M
Taupin, P
Bellahcene, A
Waltregny, D
Vieillefond, A
Poupon, MF
Citation: G. De Pinieux et al., Bone sialoprotein, bone morphogenetic protein 6 and thymidine phosphorylase expression in localized human prostatic adenocarcinoma as predictors of clinical outcome: A clinicopathological and immunohistochemical study of 43 cases, J UROL, 166(5), 2001, pp. 1924-1930
Authors:
van den Brule, FA
Waltregny, D
Castronovo, V
Citation: Fa. Van Den Brule et al., Increased expression of galectin-I in carcinoma-associated stroma predictspoor outcome in prostate carcinoma patients, J PATHOLOGY, 193(1), 2001, pp. 80-87
Authors:
Waltregny, D
Bellahcene, A
De Leval, X
Florkin, B
Weidle, U
Castronovo, V
Citation: D. Waltregny et al., Increased expression of bone sialoprotein in bone metastases compared withvisceral metastases in human breast and prostate cancers, J BONE MIN, 15(5), 2000, pp. 834-843
Authors:
van den Brule, FA
Waltregny, D
Lu, FT
Castronovo, V
Citation: Fa. Van Den Brule et al., Alteration of the cytoplasmic/nuclear expression pattern of Galectin-3 correlates with prostate carcinoma progression, INT J CANC, 89(4), 2000, pp. 361-367
Authors:
Demarche, M
Waltregny, D
van Damme, H
Limet, R
Citation: M. Demarche et al., Femoral anastomotic aneurysms: pathogenic factors, clinical presentations and treatment. A study of 142 cases, CARDIOV SUR, 7(3), 1999, pp. 315-322